Heghine Khachatryan on the Lifeline of Blood: Why Every Donor is a Hero Behind the Science
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, posted on LinkedIn:
“Blood transfusion saves lives – but only if there is a donor behind every unit of blood.
Every day, patients with cancer, blood diseases, trauma, massive bleeding, complicated pregnancies and major surgeries depend on safe blood transfusions. For them, donated blood is not just a product – it is a lifeline.
Modern transfusion medicine is highly regulated and evidence-based. Each unit of blood passes through strict testing, separation into components, and careful matching to the recipient. Behind every successful transfusion stands an invisible team: the voluntary donor, the laboratory specialists, the nurses and physicians who ensure that the right product reaches the right patient at the right time.
Yet in many hospitals we still experience critical shortages. This means postponed surgeries, limited treatment options, and sometimes the difference between life and death. Voluntary, regular, non-remunerated blood donation is the most sustainable way to guarantee safe blood for all who need it.

If you are healthy and eligible to donate, your contribution can:
• support patients with leukemia, lymphoma and aplastic anemia
• help women with severe obstetric bleeding
• stabilise patients after accidents and major surgery
• give children with hereditary blood disorders a chance to live full lives
Becoming a blood donor is one of the simplest and most powerful acts of solidarity.
It costs you around 20–30 minutes of your day, but it may add years to someone else’s life.
If you would like to support patients and our work in transfusion medicine, consider becoming a regular blood donor and invite your colleagues and friends to join you. Together we can build a culture where giving blood is a normal part of caring for our community.”
Get insights from Hemostasis Today.
-
Dec 17, 2025, 15:24Laura Dormer on a Motor Relearning Program for Chronic Stroke Patients
-
Dec 17, 2025, 15:01WSO: United Nations Has Formally Adopted the Political Declaration on NCDs and Mental Health
-
Dec 17, 2025, 14:44Bryan Unger: 1st Patient Has Been Enrolled in NuvOx Therapeutics’ Phase IIb NOVEL Trial
-
Dec 17, 2025, 14:29Sarah Richardson: Feeling So Proud to Be a Part of the Advocacy Team for the HFA
-
Dec 17, 2025, 06:28Wolfgang Miesbach on Linus Völker’s Presentation of Caplacizumab as Frontline Therapy for iTTP
-
Dec 17, 2025, 06:11Lisa Murphy Thanks Stroke Foundation Team for An Impactful, Rewarding and Incredible Year
-
Dec 17, 2025, 06:05Emmanuel J Favaloro Shares A Study on AI and Machine Learning in Thrombosis and Hemostasis
-
Dec 17, 2025, 05:54Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
-
Dec 17, 2025, 04:00Peter Verhamme on Genetic Predisposition to Thromboembolism and COVID
